ArticleESMO open2022

Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials.

E F Nassif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.